Andy
Senior Member (Voting rights)
Press release:
"MPs call on UK government to spend £100 million a year to research treatments for Long Covid
Report finds UK government has ‘not adequately funded’ Long Covid research and treatments
MPs and Peers say UK Government inaction means Long Covid will continue to impact UK productivity and essential services
For Immediate Release
The UK Government is today facing calls to ensure that the £50 million pledged for Long Covid research funding is doubled and matched each year to support the development of new treatments for Long Covid.
In a new report published by the All-Party Parliamentary Group (APPG) on Coronavirus today, cross-party MPs and Peers have recommended the UK Government double the £50 million pledged in the ‘Living with Covid’ plan each year to fund urgent new research into diagnostics and treatment, as well as providing financial support for key workers living with Long Covid.
The new report found that the UK Government’s Covid-19 policymaking has ‘continuously failed’ to take Long Covid into account, as well as failing to provide guidance, funding or support to employers and protecting children in schools. The report further found that the UK Government has not 'adequately funded’ research to identify treatments for Long Covid.
According to the latest ONS figures, an estimated 1.5 million people (2.4% of the population) are currently living with the condition in the UK, with the high number of resulting staff absences having a serious impact on the UK workforce, economy and vital public services.
Recent research conducted by the APPG estimated that 1.82 million days were lost to healthcare workers with Long Covid from March 2020 to September 2021 across 219 NHS trusts in England. Similarly, a survey conducted last month by the Chartered Institute of Personnel and Development found that a quarter of UK employers cited Long-Covid as one of the main causes of long-term sickness absence among their staff.
On Thursday, MPs will debate the government’s treatment of Long Covid and its impact on the UK workforce, which comes on the two year anniversary of the country’s first national lockdown.
Layla Moran MP, Chair of the All-Party Parliamentary Group on Coronavirus, said:
“Living with Covid inevitably means living with Long Covid too, so it is crucial that the Government rise to this moment and commit substantial annual funding for research until we have developed effective treatments for this often debilitating condition.
“Long Covid is already affecting 1.5 million people in the UK, and if the government fails to fully grasp the enormity of this challenge now, we could be hurtling towards a long-term health and workforce crisis in the future.”
Dr Dan Poulter MP, Vice-Chair of the All-Party Parliamentary Group on Coronavirus, said:
“Prematurely scrapping free testing will likely lead to rising infections, and as more people become unknowingly infected with the virus, more people will unfortunately develop Long Covid too.
“While we are currently facing other international challenges, this pandemic is sadly not over. That’s why establishing an annual fund for researching and developing treatments for Long Covid is both the economically smart and right thing to do, as in the long run, it will help us to avoid severe impacts on people’s health and the UK economy.”
David Nabarro, Special Envoy on Covid-19 for the World Health Organisation, said:
“What does it mean to live with COVID? The virus is among us. It is constantly evolving. It causes serious illness and may kill people who are susceptible. It may also lead to long COVID with the extra risks it brings.
“The present pattern is that case numbers start to climb every three months or so: this implies a need to detect surges quickly, prevent transmission, protect those most at risk and prepare for explosive outbreaks. It is a time to listen to the health workers: they know what is happening and where it may lead. They want the best for everyone.”
Report available from https://www.appgcoronavirus.uk/report-on-long-covid-2022
"MPs call on UK government to spend £100 million a year to research treatments for Long Covid
Report finds UK government has ‘not adequately funded’ Long Covid research and treatments
MPs and Peers say UK Government inaction means Long Covid will continue to impact UK productivity and essential services
For Immediate Release
The UK Government is today facing calls to ensure that the £50 million pledged for Long Covid research funding is doubled and matched each year to support the development of new treatments for Long Covid.
In a new report published by the All-Party Parliamentary Group (APPG) on Coronavirus today, cross-party MPs and Peers have recommended the UK Government double the £50 million pledged in the ‘Living with Covid’ plan each year to fund urgent new research into diagnostics and treatment, as well as providing financial support for key workers living with Long Covid.
The new report found that the UK Government’s Covid-19 policymaking has ‘continuously failed’ to take Long Covid into account, as well as failing to provide guidance, funding or support to employers and protecting children in schools. The report further found that the UK Government has not 'adequately funded’ research to identify treatments for Long Covid.
According to the latest ONS figures, an estimated 1.5 million people (2.4% of the population) are currently living with the condition in the UK, with the high number of resulting staff absences having a serious impact on the UK workforce, economy and vital public services.
Recent research conducted by the APPG estimated that 1.82 million days were lost to healthcare workers with Long Covid from March 2020 to September 2021 across 219 NHS trusts in England. Similarly, a survey conducted last month by the Chartered Institute of Personnel and Development found that a quarter of UK employers cited Long-Covid as one of the main causes of long-term sickness absence among their staff.
On Thursday, MPs will debate the government’s treatment of Long Covid and its impact on the UK workforce, which comes on the two year anniversary of the country’s first national lockdown.
Layla Moran MP, Chair of the All-Party Parliamentary Group on Coronavirus, said:
“Living with Covid inevitably means living with Long Covid too, so it is crucial that the Government rise to this moment and commit substantial annual funding for research until we have developed effective treatments for this often debilitating condition.
“Long Covid is already affecting 1.5 million people in the UK, and if the government fails to fully grasp the enormity of this challenge now, we could be hurtling towards a long-term health and workforce crisis in the future.”
Dr Dan Poulter MP, Vice-Chair of the All-Party Parliamentary Group on Coronavirus, said:
“Prematurely scrapping free testing will likely lead to rising infections, and as more people become unknowingly infected with the virus, more people will unfortunately develop Long Covid too.
“While we are currently facing other international challenges, this pandemic is sadly not over. That’s why establishing an annual fund for researching and developing treatments for Long Covid is both the economically smart and right thing to do, as in the long run, it will help us to avoid severe impacts on people’s health and the UK economy.”
David Nabarro, Special Envoy on Covid-19 for the World Health Organisation, said:
“What does it mean to live with COVID? The virus is among us. It is constantly evolving. It causes serious illness and may kill people who are susceptible. It may also lead to long COVID with the extra risks it brings.
“The present pattern is that case numbers start to climb every three months or so: this implies a need to detect surges quickly, prevent transmission, protect those most at risk and prepare for explosive outbreaks. It is a time to listen to the health workers: they know what is happening and where it may lead. They want the best for everyone.”
Report available from https://www.appgcoronavirus.uk/report-on-long-covid-2022